Ron de Graaff LL.M
Ron de Graaff LL.M has more than 40 years experience in consulting for pharmaceutical and medtech companies. He is the founder of Seijgraaf Consultancy in 1985, located in The Netherlands. Furthermore, he is one of the founders of the Agora Network and the IHC Consulting company in Switzerland. Ron has focussed his professional life on health insurance and health financing issues as well as dental care and reimbursement of medical devices and pharmaceutical products. Ron is a senior expert in issues of DRG financing (or in Dutch DBC) in the Netherlands. Over the years he has advised more than 800 private and public sector health care providers, insurers and manufacturers of pharmaceuticals and medical devices, giving advice mainly in the field of strategy and policy structures, related to and resulting from the finance structures of the Dutch healthcare system (over 2,500 projects). His past duties involved: Chairman of Umbrella Organization of Medical Technology in the Netherlands (SOMT), Chairman of the Dentists organization ANT, Chairman of a regional patient organization and various advisory roles of the Dutch Healthcare Authority and the National Reimbursement Authority.
Frans van Andel MSc, MPH, PhD
Frans van Andel, MSc, MPH, PhD Dutch nationality. Senior Partner of HEAP Research BV. Degrees in health economics (Universities of Groningen and Utrecht) and public health (Harvard, USA). PhD in pharmaceutical economics. More than 25 years of experience in market access issues involving pharmaceuticals and medical devices with work experience in the pharmaceutical industry, CRO’s and WHO. In addition, investment and healthcare restructuring projects (especially rehabilitation facilities for handicapped persons) for the public and private sector in Central and Eastern Europe, Africa, Middle East and Asia. Assignments from the health insurance sector, medical technology and pharmaceutical industries as well as institutional agencies such as the European Union, the World Bank and the Netherlands’ Government. Expert in market access issues involving pharmaceuticals and medical devices, project development sourcing, health financing and insurance and public/private mix.
Carla de Graaff
Carla de Graaff is the person responsible for the office and contacts.
She is ready to speak to you!